# Zhuhai Shutong Medical Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhuhai-shutong-medical-technology

- Industry: Biotechnology
- Headquarters: Zhuhai, China
- Website: www.generulor.com
- Latest round: Series A (Sep 5, 2023)
- Investors on record: 7

## About

Established in 2019 and based in Zhuhai, China, Zhuhai Shutong Medical Technology Co., Ltd operates as a biopharmaceutical company that focuses on the development of pharmaceutical products in the areas of early tumor screening, tumor companion diagnostics, genetic disease diagnostics and pathogen detection. The company has a standardized GMP R&D laboratory and production workshop. In September 2023, it closed series A funding led by Shanxi Growth Enterprise Leading Fund, with participation from Guangdong Technology Financial Group, Kaikai Venture Capital and Huanuo Medical Fund.

The company focuses on gene editing technology to apply the field of viral infections and related tumor diseases. Its platforms are divided into three series, which include gene editing platform, molecular diagnostic platform, and sgRNA design and off-target prediction platform. Gene editing platforms provides gene editing full-process solutions and safety assessment programs, including various gene editing tools and gene editing CRO services such as high-throughput new drug target screening, multi-pipeline off-target analysis and drug delivery. Molecular diagnostic platform includes molecular diagnostic materials, capture kits, library building kits and cfDNA assays. The sgRNA design and off-target prediction platform combines Cas-Designer, Cas-Offinder and CRISPR-Net algorithms to help users design sgRNAs with robust efficiency and low off-target effects.

The company will invest in the commercialization of gene-edited diagnostic products and innovative drug IND filings in China and the United States.

## Funding rounds

- Series A, Sep 5, 2023 — Guangdong Technology Financial Group, Shanxi Growth Enterprise Leading Fund, Kaide Innovation Capital, Huanuo Medical Fund
- Angel, Jul 7, 2022 — YF Capital, Zhongshan Investment Holding Group, Zhuhai Gree Group

## Investors

- YF Capital (https://capitalatlas.ai/funds/yf-capital) — Angel
- Zhongshan Investment Holding Group — Angel
- Zhuhai Gree Group — Angel
- Guangdong Technology Financial Group (https://capitalatlas.ai/funds/guangdong-technology-financial-group) — Series A
- Shanxi Growth Enterprise Leading Fund (https://capitalatlas.ai/funds/shanxi-growth-enterprise-leading-fund) — Series A
- Kaide Innovation Capital (https://capitalatlas.ai/funds/kaide-innovation-capital) — Series A
- Huanuo Medical Fund — Series A